Dr Reddy's Laboratories (BSP:R1DY34) Ending Cash Position : R$443 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Dr Reddy's Laboratories Ending Cash Position?

Dr Reddy's Laboratories's Ending Cash Position for the quarter that ended in Dec. 2023 was R$443 Mil.

Dr Reddy's Laboratories's quarterly Ending Cash Position increased from Jun. 2023 (R$427 Mil) to Sep. 2023 (R$805 Mil) but then declined from Sep. 2023 (R$805 Mil) to Dec. 2023 (R$443 Mil).

Dr Reddy's Laboratories's annual Ending Cash Position declined from Mar. 2021 (R$1,147 Mil) to Mar. 2022 (R$970 Mil) and declined from Mar. 2022 (R$970 Mil) to Mar. 2023 (R$366 Mil).

Dr Reddy's Laboratories Ending Cash Position Historical Data

The historical data trend for Dr Reddy's Laboratories's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Ending Cash Position Chart

Dr Reddy's Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Ending Cash Position

Get a 7-Day Free Trial

123.14

128.60

1,146.84

970.07

365.89

Dr Reddy's Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															398.08	365.89	426.66	804.69	443.46

Dr Reddy's Laboratories Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Dr Reddy's Laboratories's Ending Cash Position for the fiscal year that ended in Mar. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	940.334	+	-574.444
	=	366

Dr Reddy's Laboratories's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	796.584	+	-353.122
	=	443

Dr Reddy's Laboratories Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories (BSP:R1DY34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (BSP:R1DY34) » Definitions » Ending Cash Position

Traded in Other Exchanges

RDY:USA DRREDDY:India 500124:India RDDA:Germany RDDA:Germany

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories (BSP:R1DY34) Headlines

No Headlines